Trial shows Gilead’s Lenacapavir reduces HIV infections by 96%
Introducing the Future of HIV Prevention: Gilead’s Lenacapavir Exciting news in the world of healthcare as Gilead announces groundbreaking results from a second large study on their innovative HIV prevention injectable drug, lenacapavir. According to … Read more